|
HHS-wide Stigma Scientific Interest Group (Stigma SIG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA, FDA, SAMHSA, IHS
|
FIC, NIMH, NCI, NIDA, NIAAA, NINDS, NICHD, OD/DPCPSI/OBSSR, NIMHD, NINR, NIAID, NIDCR
|
Interagency working group focused on coordinating activities and sharing information related to health-related stigma research. The group meets monthly to update one another on related grant programs, upcoming conference opportunities, discuss emerging research on stigma reduction methods and interventions, and listen to/discuss presentations from invited stigma research experts.
|
|
HHS-Wide Stigma Workgroup
|
Resource Development
|
CDC, FDA, HRSA, IHS, SAMHSA
|
NIMH
|
Building on the momentum of the 2019 BMC Medicine Stigma Collection and the 2019 NIMH Global Mental Health Webinar, representatives from the National Institutes of Health (NIH) formed a Stigma Planning Workgroup to harness the momentum of the 2019 BMC Medicine Stigma Collection and the 2019 NIMH Global Mental Health Webinar and to coordinate and chart a course forward for research related to stigma. The overall goal was to provide leadership, vision, and support to stigma research funded by the NIH. As the NIH-focused workgroup started to meet and gain traction, other federal partners expressed interest in joining. For example, staff from the Centers for Disease Control and Prevention (CDC), Health Resources and Services and Administration (HRSA), Indian Health Services (IHS), Food and Drug Administration (FDA), and Substance Abuse and Mental Health Services Administration (SAMHSA) joined as well. Thus, moving forward this workgroup consists of Health and Human Services (HHS) partners aiming to promote cross-cutting stigma research and related activities and to enhance opportunities for knowledge transfer and collaborative learning in the field of stigma and discrimination research. To achieve this goal, the workgroup agrees to pursue several broad actions, including: (1) Clearly defining stigma and discrimination for the purpose of the workgroup; (2) Organizing a speaker’s series to understand current stigma research findings, and interests within each federal agency; (3) Identifying and defining current stigma and discrimination research successes and challenges within each agency; (4) Identifying shared and individual priorities for each agency and how future activities could address identified challenges; (5) See enclosed list of HHS partner interests; (6) Advancing stigma and discrimination research training to build knowledge and skills among stigma-focused researchers and among other researchers seeking to increase capacity to conduct high-quality stigma and discrimination research; (7) Advancing the broader dissemination of stigma-related research; (8) Aligning technical assistance efforts to support one another; and (9) Supporting cross-cutting stigma and discrimination research as a field.
|
|
HHS/Office of the Secretary, Office of the Assistant Secretary for Planning and Evaluation (OS-ASPE) - Reentry/Criminal Justice Working |Group.
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, HRSA, SAMHSA
|
NHLBI, NIDA, NIMH
|
Through the Federal Interagency Reentry Council, federal agencies are working together to enhance community safety and well-being, assist those returning from prison and jail in becoming productive citizens, and save taxpayer dollars by lowering the direct and collateral costs of incarceration. Because reintegration to the community after incarceration intersects with issues of health, housing, education, employment, family, faith, and community well-being, the U.S Department of Health and Human Services (HHS) and other federal agencies are focusing on the reentry population with activities that aim to improve outcomes in these areas.
|
|
HIV Implementation Science Summit for Ending the HIV Epidemic (EHE) Supplement Projects
|
Meeting/ Workshop
|
CDC, HRSA
|
NIAID, NICHD, NIDA, NIMH, OD/DPCPSI/OAR
|
This HIV Implementation Science Summit brought together investigators, implementation partners, and federal agencies to identify approaches for using implementation science to end the HIV epidemic in the United States. Attendees learned about (1) the projects responding to the EHE initiative through science–practice partnerships, (2) key implementation science concepts and methods and examples of how these are applied in HIV research, and (3) capacity-building services provided by the Implementation Science Coordination, Consultation, and Collaboration Initiative (ISC3I) coordinating center.
|
|
HIV Pre-exposure Prophylaxis (PrEP) Implementation Science in HRSA Primary Health Care Settings
|
Research Initiative
|
HRSA
|
NIMH
|
The National Institute of Mental Health (NIMH) Division of AIDS Research (DAR) collaborated with the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau and Bureau of Primary Health Care to develop a research funding opportunity (NOT-MH-020-050) which aims to support implementation science on the scale-up of HIV prevention services within selected HRSA-funded health centers under the federal Ending the HIV Epidemic initiative. The funding opportunity provides one-year administrative supplements to NIH research awards that would work collaboratively with personnel at a partnering HRSA-funded health center(s) to understand and enhance their delivery of HIV testing and/or HIV pre-exposure prophylaxis (PrEP) by concurrently answering key research questions of import to the clinics as well as the wider HIV prevention community. Three applications were funded from this opportunity, and NIMH/DAR will continue to inform the HRSA Bureau of Primary Health Care on progress and outcomes, and plan for future collaboration.
|
|
HIV/AIDS Cancer Match Study (HACM)
|
Research Initiative
|
CDC
|
NCI
|
A study linking HIV and cancer registries in multiple US regions to evaluate the spectrum of cancer risk in people living with HIV
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model.
|
|
HRSA Advancing Precision Medicine (HRSA APM)
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
OD/AoU
|
In 2018, HRSA awarded $456K to 40 HRSA FQHCs to work on engagment activites and EHR sharing for AoU. The period of performance ran through SEptember 2020 with some FQHCs operating on a No Cost Extension through December 2020. NIH continues to meet with HRSA monthly to discuss the potential for future opportunities to add FQHCs to the All of Us Research Program.
|
|
HRSA Maternal and Child Health Bureau Grand Challenges: Promoting Pediatric Primary Prevention ("P4 Challenge") Federal Judge
|
Meeting/ Workshop
|
CDC, CMS, HRSA
|
NICHD
|
This challenge supports innovative innovative approaches to increase well-child visits and immunizations within primary care settings. This is a HRSA/MCHB-led initiative
|
|
HRSA Maternal and Child Health Bureau Grand Challenges: remote pregnancy monitoring panelist
|
Research Initiative
|
CDC, CMS, HRSA
|
NICHD
|
This challenge supports innovative technology-based solutions that help providers remotely monitor the health of pregnant women, and empower women to make informed decisions about their own care. The goal of this challenge is to use technology to allow women facing various barriers to care to experience the benefits of an ongoing relationship with a health-care provider to keep them and their children healthy.
|